Results 11 to 20 of about 1,694 (117)

Luspatercept for Transfusion-Dependent Beta-Thalassemia: Real-World Experience in a Large Cohort of Patients From Italy. [PDF]

open access: yesAm J Hematol
American Journal of Hematology, Volume 100, Issue 9, Page 1651-1655, September 2025.
Origa R   +36 more
europepmc   +2 more sources

Real-world evidence supports the safety and efficacy profile of luspatercept in clinically complex and heavily iron-overloaded patients. [PDF]

open access: yesBr J Haematol
British Journal of Haematology, Volume 208, Issue 6, Page 2320-2325, June 2026.
Gianesin B   +29 more
europepmc   +2 more sources

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa

open access: yeseJHaem, Volume 4, Issue 3, Page 595-601, August 2023., 2023
Novelties: 1. This work shows the efficacy of hydroxyurea (HU) treatment of sickle cell anemia in adult patients in a low‐resource country. 2. HU treatment can result in clinical improvement despite the absence of biological changes. 3. The specific clinical relevance of this work is the need to continue treatment with HU even if clinical improvement ...
Paul Lumbala Kabuyi   +9 more
wiley   +1 more source

S273: LONG‐TERM ERYTHROID RESPONSE DATA FROM PATIENTS (PTS) WITH NON‐TRANSFUSION‐DEPENDENT ΒETA‐THALASSEMIA (NTDT) RECEIVING LUSPATERCEPT IN THE BEYOND TRIAL

open access: yes, 2023
HemaSphere, Volume 7, Issue S3, August 2023.
Ali T. Taher   +12 more
wiley   +1 more source

P1447: MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO‐OCCLUSIVE CRISES IN ITALY

open access: yes, 2023
HemaSphere, Volume 7, Issue S3, August 2023.
Chuka Udeze   +6 more
wiley   +1 more source

P1449: SAFETY PROFILE OF KETOROLAC CONTINUOUS INFUSION IN SICKLE CELL RELATED ACUTE VASO‐OCCLUSIVE CRISIS

open access: yes, 2023
HemaSphere, Volume 7, Issue S3, August 2023.
Valeria Maria Pinto   +9 more
wiley   +1 more source

P1452: MORTALITY AND CLINICAL COMPLICATIONS AMONG PATIENTS WITH TRANSFUSION‐DEPENDENT BETA‐THALASSEMIA IN ITALY

open access: yes, 2023
HemaSphere, Volume 7, Issue S3, August 2023.
Chuka Udeze   +6 more
wiley   +1 more source

EVALUAREA HEMOCROMATOZEI ÎN β TALASEMIA MAJORĂ [PDF]

open access: yesRomanian Journal of Pediatrics, 2011
β Talasemia majoră este o anemie ereditară severă care necesită tratament transfuzional toată viaţa, fără de care pacientul nu poate supravieţui. Regimul transfuzional cronic determină hemocromatoza secundară care trebuie monitorizată regulat, în ...
Adriana Diaconu, Alice Bălăceanu
doaj   +1 more source

P1461: INFLAMMATORY AND SENESCENCE‐ASSOCIATED MEDIATORS AFFECT THE PERSISTENCE OF HUMORAL RESPONSE TO COVID‐19 MRNA VACCINATION IN TRANSFUSION‐DEPENDENT BETA‐THALASSEMIC PATIENTS

open access: yes, 2023
HemaSphere, Volume 7, Issue S3, August 2023.
Veronica Bordoni   +20 more
wiley   +1 more source

Approche de l'état podologique du patient diabétique hémodialysé chronique dans un centre hospitalier Marocain

open access: yesThe Pan African Medical Journal, 2013
De plus en plus de patients diabétiques sont pris en charge en HDC. Les conséquences sont multiples, notamment les problèmes de pied diabétique qui demeurent mal connus du patient diabétique et des soignants ce qui retentit considérablement sur la ...
Nawal Benabdellah   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy